The double-stranded RNA (dsRNA)-binding domain of the human p68 kinase has been loaliz to the N-terminal half of the enzyme by using progressive deletion analysis and in vitro binding assays. To further define the domains responsible for binding to dsRNA, we cloned the mouse dsRNA-activated p65 kinase and used sequence alignment to identify conserved domains in the N-terminal region.
Consequently, it has been suggested that the dsRNAactivated kinase may also phosphorylate other substrates that are involved in signaling or transcriptional activation of IFN and IFN-inducible genes.
We have reported (13) the isolation and characterization of the cDNA for human p68 kinase. This cDNA contains all of the conserved domains represented in protein kinases (14) , and the sequence confirmed previous observations (15, 16) that p68 is a member of the serine/threonine kinases. The in vitro translated product of the cDNA is able to bind to dsRNA, be recognized by a monoclonal antibody to native p68 kinase, autophosphorylate, and phosphorylate eIF2a in vitro (13, 17, 18) . When expressed in the yeast Saccharomyces cerevisiae, the human p68 kinase exhibits a growthsuppressing phenotype, which is correlated with phosphorylation of yeast eIF2a (18) . Therefore, these studies provide a basis for further analysis of the relationship between structure and function of the p68 kinase.
To reveal the mechanism for the regulation of p68 kinase activity by dsRNA, we have performed a deletion analysis of the p68 kinase to reveal domains important for binding to dsRNA. We have cloned and sequenced § the murine p65 kinase and used sequence alignment between p68 and p65 to identify conserved regions in the N-terminal domain. Sitedirected mutagenesis of these segments indicates that positively charged domains within the conserved regions are responsible for complexing to dsRNA and activating the kinase activity.
MATERIALS AND METHODS
Mouse p65 cDNA Cloning and Sequencing. A cDNA library in phage Agtl1 made from the mouse mammary carcinoma FM3A cell line, obtained from J. Hassel (McMaster University, Hamilton, ON), was screened by using the Xba I-Pst I (1.8 kilobases (kb)] fragment of the human p68 cDNA (13) as a probe. Hybridization was done at 500C in 5x SSC, 5x Denhardt's solution, 0.1% SDS, 9o dextran sulfate, and 0.1 mg of salmon sperm DNA per ml for 20 hr (lx SSC = 0.15 M NaCl/0.015 M sodium citrate, pH 7; lx Denhardt's solution = 0.02% bovine serum albumin/0.02% polyvinylpyrrolidone/0.02% Ficoll). The membranes were washed twice in 3x SSC/0.1% SDS, once in lx SSC/0.1% SDS at room temperature, and once in lx SSC/0.1% SDS at 500C. The positive clones were isolated, and EcoRI inserts were subcloned into the vectors pGEM-3Z (Promega) and M13mpl8 (New England Biolabs). Sequencing of both strands of deletion subclones in M13mpl8 made with cyclone I biosystem kit (IBI) was done by Sanger's dideoxy chaintermination method with a kit from Pharmacia.
Mutagenesis of p68 Kinase. Different-size fragments of p68 cDNA were isolated and inserted into pGEM-3Z as shown in Fig. 1 . For site-directed mutations (Table 1) , the p68 cDNA cloned in pBluescript was used as a template. The template DNA was amplified in strain CJ236 (dut-ung-F') with uracil incorporation into the strand at some thymidine positions. The mutant 27-mers (listed in tThe percentage is based on the density scanning of a typical binding experiment (see Fig. 4 ), with the binding efficiency of wild-type p68 as 100%. §The inhibition is illustrated in Fig. 5 .
[35S]methionine at 10 uCi (370 kBq)/ml, and H20 to 50 Al.
The reaction was at 30°C for 60 min. Poly(rI)-Poly(rC) Binding Assay. In vitro translated products were tested for poly(rI)'poly(rC) binding by using poly(rI)-poly(rC)-cellulose (a gift from R. H. Silverman) as described (19) . dsRNA-bound and unbound proteins were analyzed by NaDodSO4/PAGE through 10% gels. The percentage of p68 kinase bound was quantified by taking the binding efficiency [the ratio of dsRNA-bound and total protein applied to poly(rI)-poly(rC)-cellulose, estimated by scanning of autoradiographs] of wild-type p68 kinase as 100o and comparing to the different mutants.
Expression in Yeast. Mutant p68 kinase cDNA inserts were cut from pBluescript and cloned into the yeast expression vector pEMBLyex4 and expressed in S. cerevisiae as detailed (18) . The expression plasmids were introduced into the haploid yeast strain W303-la, and transformed strains were grown for 2 days at 30°C on agar containing synthetic medium that lacked uracil and contained 2% glucose or galactose as the sole carbon source.
RESULTS
Localization of the dsRNA-Binding Domain to the N-Terminal Region of the p68 Kinase. To define the functional domain for dsRNA binding by the p68 kinase, we cloned the full-length p68 cDNA, the 5' and 3' halves of the cDNA, and a set of fragments progressively deleted from the 3' end in pGEM-3Z. These constructs were in vitro transcribed, and the derived cRNA was translated in vitro with the incorpo- poly(rI)-poly(rC), a synthetic dsRNA. The dsRNA-binding activity was located in the N-terminal portion of the protein (Fig. 1) . Through the examination of a nested set of deletion mutants (Fig. 1 ), we were able to localize the dsRNA-binding function to within 120 amino acids of the N terminus, as pGEM-8 only contains the cDNA sequence of p68 from position 1 to 383 (Fig. 1) The 1886-nucleotide sequence of C13, although not a full-length clone, encodes a 515-amino acid protein (Fig. 2) . This compares to the human p68 kinase, which comprises 550 amino acids (13) . All of the 15 conserved amino acid residues identified by Hanks et al. (14) in the proposed kinase catalytic domains can be found in the p65 kinase (Fig. 2) . For example, Lys-271 in catalytic domain II is an invariant residue in all of the characterized kinases and appears to be directly involved in phosphotransfer reaction (14) . Changing this lysine to arginine or proline abolished the kinase activity ofp68 in vitro and in vivo (17, 18) . The amino acid sequences of Asp-LeuLys-Pro-Gly-Asn at positions 376-381 in catalytic domain VI and Gly-Thr-Leu-Gln-Tyr-Met-Ser-Pro-Glu at positions 413-421 in catalytic domain VIII in p65 indicate a feature diagnostic of serine/threonine kinases (14) . We have also noted that the p65 kinase sequence is almost identical to that reported for a murine serine/threonine kinase (designated TIK for antiphospholyrosine immunoreactive kinase) isolated by screening an expression library with antiphosphotyrosine antibodies (20) . The sequence differences between the two cDNAs are minor and there seems little doubt that TIK is actually the murine interferon-induced p65 kinase.
The 550 amino acids ofp68 were aligned with the 515 amino acids of p65 (Fig. 3 ) by using the computer program BESTFIT. Of the amino acid residues of p68 and p65, 61% are identical. When conservative changes are taken into account, the overall homology is 71%. Nearly 100% homology exists between p68 and p65 in the nine catalytic domains proposed by Hanks et al. (14) for kinases. Of particular interest are the homologous regions in the N-terminal domain between p68 and p65. We have noted (18) that there is sequence similarity in the catalytic domains between the human p68 kinase, mouse p65 kinase, heme-regulated inhibitor (HRI; ref. 21) , and yeast kinase GCN2, specifically in a "kinase insert" region located between catalytic domains IV to VI. GCN2 is a ribosome-associated protein kinase whose substrate is yet to be identified. Ten amino acids (Leu-Phe-Ile-Gln-Met-GluPhe-Cys-Asp-Lys) in particular that are located in this "kinase insert" region could play a role in recognition of their putative common substrate, eIF2a.
Identification of dsRNA-Bding Rons In p68. Sequence comparison reveals highly conserved regions in the N-terminal domains between p68 and p65 (Fig. 3) . Furthermore, these regions are enriched for positively charged amino acids, especially arginine, typical of the RNA-binding motif for RNA-binding proteins (22) . To demonstrate a role in binding to dsRNA, we selected four arginine-or lysine-rich regions of p68 and p65 that are almost 100% homologous. In each area, we deleted 10-12 amino acids ( Table 1) . As a control, we made another mutant in which we deleted a serine/threoninerich region. All these mutant constructs were efficiently transcribed and translated in vitro (Fig. 4) . The radiolabeled translational products were then tested for their ability to bind to poly(rI) poly(rC)-cellulose (Fig. 4) Attempts were made to examine the effect of these deletions on autophosphorylation and, therefore, the activation of the kinase activity. However, as these mutants harbor deletions in the N-terminal region of the kinase, which contains the binding site for the monoclonal antibody used for in vitro kinase assay, this assay was not informative. Therefore, we took another approach by examining their inhibitory effect on yeast cell growth. Our previous work has shown that p68 kinase suppression of yeast cell growth results from activation of the kinase by an endogenous activator in S. cerevisiae and phosphorylation of yeast eIF2a (18 (Fig. 4) . This is consistent with their poly(rI)-poly(rC) binding phenotype as determined by the in vitro assay ( Fig. 5 and Table 1 ). These observations suggest that the specific regions in the N terminus of the p68 kinase are responsible for dsRNA (22) . In our mutant 1 of the p68 kinase (Table 1) , the deleted region also contains three arginine residues and mutant 2 contains one arginine and four lysine residues. Thus, these regions all have net positive charges. Furthermore, these segments are almost 100lo homologous between human and mouse, suggesting their importance in the regulatory functions of the kinase. Similar arginine-rich regions can be seen in the N-terminal domain of 2',5'-oligoadenylate synthetase, and these have been found recently to be involved in binding to dsRNA (23) . Further studies using point mutagenesis are needed to define the role of these amino acids in contacting dsRNA. Our results do not rule out the possibility that there are other dsRNA-binding sites existing in the kinase. In fact, several truncated molecules of the human p68 kinase that are 90 (EcoRI), 155 (Eae I), and 242 (Ban I) amino acids from the N terminus have been tested for binding to reovirus dsRNA. Only the Ban I peptide was able to bind to reovirus dsRNA, whereas both the EcoRI and Eae I peptides were deficient in binding (17) . This result differs from our observations shown in Fig. 1 . We note that the small peptides produced from pGEM-11 (comparable to Eae I) and pGEM-8 do bind to poly(rI)-poly(rC), but at much reduced levels. Perhaps different binding sites or affinities of various dsRNAs can explain the discrepancies in results. Taken together, we would suggest that, although the predominant dsRNA binding sites lie between amino acids 39 and 50 and 58 and 69 of the p68 kinase, other parts of the N-terminal domain are required to maintain the protein conformation for efficient binding of dsRNA. Further quantitative analysis of the binding affinity between these mutants and various dsRNAs is needed to test the hypothesis that several dsRNA binding sites with different affinities exist in the p68 kinase.
